Selected research
Industry Research
Valsartan-Hydrochlorothiazide Industry Research Report 2026
Market perspective
The global Valsartan-Hydrochlorothiazide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Valsartan-Hydrochlorothiazide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Valsartan-Hydrochlorothiazide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Valsartan-Hydrochlorothiazide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Valsartan-Hydrochlorothiazide include Teva, Novartis, Mylan, Huaren Pharmaceutical, Zhejiang Huahai Pharmaceutical, Torrent Pharmaceuticals, Par Pharmaceutical, MACLEODS and Lupin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Valsartan-Hydrochlorothiazide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Valsartan-Hydrochlorothiazide Market by Company
Teva
Novartis
Mylan
Huaren Pharmaceutical
Zhejiang Huahai Pharmaceutical
Torrent Pharmaceuticals
Par Pharmaceutical
MACLEODS
Lupin
Cisen Pharmaceutical
Chongqing Conquer Pharmaceutical
Beijing Second Pharmaceutical
Aurobindo Pharma
APOTEX
Alembic Pharmaceuticals
Valsartan-Hydrochlorothiazide Segment by Type
Tablet
Capsule
Valsartan-Hydrochlorothiazide Segment by Application
Hospital
Drug Store
Valsartan-Hydrochlorothiazide Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan-Hydrochlorothiazide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Valsartan-Hydrochlorothiazide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan-Hydrochlorothiazide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Valsartan-Hydrochlorothiazide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Valsartan-Hydrochlorothiazide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Valsartan-Hydrochlorothiazide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet
- Capsule
Applications
- Hospital
- Drug Store
Companies covered
- Teva
- Novartis
- Mylan
- Huaren Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Torrent Pharmaceuticals
- Par Pharmaceutical
- MACLEODS
- Lupin
- Cisen Pharmaceutical
- Chongqing Conquer Pharmaceutical
- Beijing Second Pharmaceutical
- Aurobindo Pharma
- APOTEX
- Alembic Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Valsartan-Hydrochlorothiazide Market Size (2021-2032)
- 2.2.2 Global Valsartan-Hydrochlorothiazide Sales (2021-2032)
- 2.2.3 Global Valsartan-Hydrochlorothiazide Market Average Price (2021-2032)
- 2.3 Valsartan-Hydrochlorothiazide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet
- 2.3.3 Capsule
- 2.4 Valsartan-Hydrochlorothiazide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Valsartan-Hydrochlorothiazide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Valsartan-Hydrochlorothiazide Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Valsartan-Hydrochlorothiazide Revenue of Manufacturers (2021-2026)
- 3.4 Global Valsartan-Hydrochlorothiazide Average Price by Manufacturers (2021-2026)
- 3.5 Global Valsartan-Hydrochlorothiazide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Valsartan-Hydrochlorothiazide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Valsartan-Hydrochlorothiazide, Product Type & Application
- 3.8 Global Manufacturers of Valsartan-Hydrochlorothiazide, Established Date
- 3.9 Global Valsartan-Hydrochlorothiazide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Valsartan-Hydrochlorothiazide Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Valsartan-Hydrochlorothiazide Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Valsartan-Hydrochlorothiazide Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Huaren Pharmaceutical
- 4.4.1 Huaren Pharmaceutical Company Information
- 4.4.2 Huaren Pharmaceutical Business Overview
- 4.4.3 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Huaren Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.4.5 Huaren Pharmaceutical Recent Developments
- 4.5 Zhejiang Huahai Pharmaceutical
- 4.5.1 Zhejiang Huahai Pharmaceutical Company Information
- 4.5.2 Zhejiang Huahai Pharmaceutical Business Overview
- 4.5.3 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Huahai Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.5.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 4.6 Torrent Pharmaceuticals
- 4.6.1 Torrent Pharmaceuticals Company Information
- 4.6.2 Torrent Pharmaceuticals Business Overview
- 4.6.3 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Torrent Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
- 4.6.5 Torrent Pharmaceuticals Recent Developments
- 4.7 Par Pharmaceutical
- 4.7.1 Par Pharmaceutical Company Information
- 4.7.2 Par Pharmaceutical Business Overview
- 4.7.3 Par Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Par Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.7.5 Par Pharmaceutical Recent Developments
- 4.8 MACLEODS
- 4.8.1 MACLEODS Company Information
- 4.8.2 MACLEODS Business Overview
- 4.8.3 MACLEODS Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 MACLEODS Valsartan-Hydrochlorothiazide Product Portfolio
- 4.8.5 MACLEODS Recent Developments
- 4.9 Lupin
- 4.9.1 Lupin Company Information
- 4.9.2 Lupin Business Overview
- 4.9.3 Lupin Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lupin Valsartan-Hydrochlorothiazide Product Portfolio
- 4.9.5 Lupin Recent Developments
- 4.10 Cisen Pharmaceutical
- 4.10.1 Cisen Pharmaceutical Company Information
- 4.10.2 Cisen Pharmaceutical Business Overview
- 4.10.3 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cisen Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.10.5 Cisen Pharmaceutical Recent Developments
- 4.11 Chongqing Conquer Pharmaceutical
- 4.11.1 Chongqing Conquer Pharmaceutical Company Information
- 4.11.2 Chongqing Conquer Pharmaceutical Business Overview
- 4.11.3 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Chongqing Conquer Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.11.5 Chongqing Conquer Pharmaceutical Recent Developments
- 4.12 Beijing Second Pharmaceutical
- 4.12.1 Beijing Second Pharmaceutical Company Information
- 4.12.2 Beijing Second Pharmaceutical Business Overview
- 4.12.3 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beijing Second Pharmaceutical Valsartan-Hydrochlorothiazide Product Portfolio
- 4.12.5 Beijing Second Pharmaceutical Recent Developments
- 4.13 Aurobindo Pharma
- 4.13.1 Aurobindo Pharma Company Information
- 4.13.2 Aurobindo Pharma Business Overview
- 4.13.3 Aurobindo Pharma Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Aurobindo Pharma Valsartan-Hydrochlorothiazide Product Portfolio
- 4.13.5 Aurobindo Pharma Recent Developments
- 4.14 APOTEX
- 4.14.1 APOTEX Company Information
- 4.14.2 APOTEX Business Overview
- 4.14.3 APOTEX Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 APOTEX Valsartan-Hydrochlorothiazide Product Portfolio
- 4.14.5 APOTEX Recent Developments
- 4.15 Alembic Pharmaceuticals
- 4.15.1 Alembic Pharmaceuticals Company Information
- 4.15.2 Alembic Pharmaceuticals Business Overview
- 4.15.3 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Alembic Pharmaceuticals Valsartan-Hydrochlorothiazide Product Portfolio
- 4.15.5 Alembic Pharmaceuticals Recent Developments
5 Global Valsartan-Hydrochlorothiazide Market Scenario by Region
- 5.1 Global Valsartan-Hydrochlorothiazide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2021-2032
- 5.2.1 Global Valsartan-Hydrochlorothiazide Sales by Region: 2021-2026
- 5.2.2 Global Valsartan-Hydrochlorothiazide Sales by Region: 2027-2032
- 5.3 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2021-2032
- 5.3.1 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2021-2026
- 5.3.2 Global Valsartan-Hydrochlorothiazide Revenue by Region: 2027-2032
- 5.4 North America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
- 5.4.1 North America Valsartan-Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
- 5.4.3 North America Valsartan-Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
- 5.5.1 Europe Valsartan-Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
- 5.5.3 Europe Valsartan-Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Valsartan-Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Valsartan-Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
- 5.7.1 South America Valsartan-Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
- 5.7.3 South America Valsartan-Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Valsartan-Hydrochlorothiazide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Valsartan-Hydrochlorothiazide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Valsartan-Hydrochlorothiazide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Valsartan-Hydrochlorothiazide Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2021-2032)
- 6.1.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Valsartan-Hydrochlorothiazide Sales Market Share by Type (2021-2032)
- 6.2 Global Valsartan-Hydrochlorothiazide Revenue by Type (2021-2032)
- 6.2.1 Global Valsartan-Hydrochlorothiazide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Type (2021-2032)
- 6.3 Global Valsartan-Hydrochlorothiazide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2021-2032)
- 7.1.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Valsartan-Hydrochlorothiazide Sales Market Share by Application (2021-2032)
- 7.2 Global Valsartan-Hydrochlorothiazide Revenue by Application (2021-2032)
- 7.2.1 Global Valsartan-Hydrochlorothiazide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Valsartan-Hydrochlorothiazide Revenue Market Share by Application (2021-2032)
- 7.3 Global Valsartan-Hydrochlorothiazide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Valsartan-Hydrochlorothiazide Value Chain Analysis
- 8.1.1 Valsartan-Hydrochlorothiazide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Valsartan-Hydrochlorothiazide Production Mode & Process
- 8.2 Valsartan-Hydrochlorothiazide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Valsartan-Hydrochlorothiazide Distributors
- 8.2.3 Valsartan-Hydrochlorothiazide Customers
9 Global Valsartan-Hydrochlorothiazide Analyzing Market Dynamics
- 9.1 Valsartan-Hydrochlorothiazide Industry Trends
- 9.2 Valsartan-Hydrochlorothiazide Industry Drivers
- 9.3 Valsartan-Hydrochlorothiazide Industry Opportunities and Challenges
- 9.4 Valsartan-Hydrochlorothiazide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst